ClinicalTrials.gg
RecruitingNCT07909278Updated Nov 2, 2026

Surgical Guide Versus Freehand Dental Implants Placement

An interventional study of Static Computer-Assisted Implant Surgery (CAIS) and Conventional Freehand Implant Placement in Dental Implant Placement, sponsored by Khadyjah Ali Ali Alrassas. Recruiting at 1 site in Yemen. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by Khadyjah Ali Ali Alrassas · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Jul 2025, registered Oct 2026).
  • Started Jul 2025; still recruiting 1 year 3 months later.
Updated Nov 2, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This randomized clinical trial compares the accuracy of dental implant placement performed using a surgical guide with that achieved using the conventional freehand technique. Participants requiring dental implant placement are allocated to either guided implant placement or freehand implant placement. The postoperative position of the implants is compared with the virtually planned implant position using three-dimensional image superimposition. The primary objective is to determine whether the use of a surgical guide improves the positional accuracy of dental implant placement compared with the freehand approach.

02

Conditions studied

  • Dental Implant Placement

Keywords

  • Dental Implants
  • Guided Implant Surgery
  • Surgical Guide
  • Freehand Implant Placement
  • Implant Placement Accuracy
  • Computer-Guided Implant Surgery
  • CBCT Superimposition
  • Three-Dimensional Accuracy
03

In context

Lead sponsor

This is the only study on the registry with Khadyjah Ali Ali Alrassas as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Partially edentulous patients in need of one or more dental implants.
  • Good overall health with no systemic conditions that impair healing.
  • Absence of systemic diseases.
  • Excellent oral hygiene.
  • Patients over 18 years of age.
  • Cooperative patients motivated to attend follow-up and maintenance visits.
  • Patients who agree to sign an form.

Exclusion criteria

Exclusion Criteria:

  • Systemic conditions or pharmacological therapies that would render the intervention (e.g., uncontrolled diabetes, states, treatment with oral or parenteral bisphosphonates, or osteoporosis).
  • Poor oral hygiene.
  • Heavy smokers (>10 cigarettes/day).
  • Pregnant patients, patients under 18 years of age, and elderly patients over 65 years of age.
  • Patients who are uncooperative or unable to attend scheduled follow-up visits.
  • Patients requiring extensive bone grafting.
  • Limited mouth opening.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Static Computer-Assisted Implant Surgery (CAIS)

    Participants assigned to this arm will undergo dental implant placement using a static computer-assisted implant surgery (CAIS) protocol with a digitally planned, tooth-supported surgical guide.

    Procedure: Static Computer-Assisted Implant Surgery (CAIS)

  • Active comparator
    Conventional Freehand Implant Placement

    Participants assigned to this arm will undergo conventional freehand dental implant placement following preoperative CBCT-based implant planning, without the use of a surgical guide during implant placement.

    Procedure: Conventional Freehand Implant Placement

Interventions

  • ProcedureStatic Computer-Assisted Implant Surgery (CAIS)

    Dental implants will be placed using a digitally planned, tooth-supported static surgical guide. Implant osteotomy preparation and implant insertion will be performed according to a fully guided surgical protocol.

  • ProcedureConventional Freehand Implant Placement

    Dental implants will be placed using a conventional freehand surgical approach following preoperative CBCT-based implant planning, without the use of a static surgical guide during implant placement.

06

What researchers measure

Primary outcomes

  1. Angular Deviation of Dental Implant Placement

    Angular deviation will be defined as the angle, expressed in degrees, between the longitudinal axes of the virtually planned and actually placed dental implants. The deviation will be determined by three-dimensional superimposition of the planned and postoperative implant positions.

    Time frame: 1 month after implant placement

  2. Three-Dimensional Deviation at the Implant Apex (mm)

    The three-dimensional linear distance between the virtually planned and actual postoperative implant apex positions will be measured following three-dimensional superimposition. The deviation will be expressed in millimeters (mm).

    Time frame: 1 month after implant placement

  3. Three-Dimensional Deviation at the Implant Shoulder (mm)

    The three-dimensional linear distance between the virtually planned and actual postoperative implant shoulder positions will be measured following three-dimensional superimposition. The deviation will be expressed in millimeters (mm).

    Time frame: 1 month after implant placement

  4. Mesiodistal Deviation at the Implant Shoulder

    The mesiodistal positional deviation at the implant shoulder will be measured in millimeters (mm) by comparing the virtually planned and actual postoperative implant positions using three-dimensional superimposition. Positive values indicate distal deviation, whereas negative values indicate mesial deviation.

    Time frame: 1 month after implant placement

  5. Buccolingual Deviation at the Implant Shoulder

    The buccolingual positional deviation at the implant shoulder will be measured in millimeters (mm) by comparing the virtually planned and actual postoperative implant positions using three-dimensional superimposition. Positive values indicate lingual deviation, whereas negative values indicate buccal deviation.

    Time frame: 1 month after implant placement

  6. Apicocoronal Deviation at the Implant Shoulder

    The apicocoronal positional deviation at the implant shoulder will be measured in millimeters (mm) by comparing the virtually planned and actual postoperative implant positions using three-dimensional superimposition. Positive values indicate apical deviation, whereas negative values indicate coronal deviation.

    Time frame: 1 month after implant placement

  7. Mesiodistal Deviation at the Implant Apex

    The mesiodistal positional deviation at the implant apex will be measured in millimeters (mm) by comparing the virtually planned and actual postoperative implant positions using three-dimensional superimposition. Positive values indicate distal deviation, whereas negative values indicate mesial deviation.

    Time frame: 1 month after implant placement

  8. Buccolingual Deviation at the Implant Apex

    The buccolingual positional deviation at the implant apex will be measured in millimeters (mm) by comparing the virtually planned and actual postoperative implant positions using three-dimensional superimposition. Positive values indicate lingual deviation, whereas negative values indicate buccal deviation.

    Time frame: 1 month after implant placement

  9. Apicocoronal Deviation at the Implant Apex

    The apicocoronal positional deviation at the implant apex will be measured in millimeters (mm) by comparing the virtually planned and actual postoperative implant positions using three-dimensional superimposition. Positive values indicate apical deviation, whereas negative values indicate coronal deviation.

    Time frame: 1 month after implant placement

07

Study locations

1 of 1 sites recruiting
  • Faculty of dentistry sana'a university
    Sanaa, Yemen
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared because no formal data-sharing plan was included in the approved study protocol. Study findings will be reported in aggregate form while maintaining participant confidentiality and privacy.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2025 (actual). Primary completion is estimated for Mar 2027, 20 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 5, 2026
First posted
Nov 2, 2026
StartActual
Jul 15, 2025
Primary completionEst.
Mar 2027
CompletionEst.
Mar 2027
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07909278
Lead sponsor
Khadyjah Ali Ali Alrassas
Responsible party
Khadyjah Ali Ali Alrassas (Master's Candidate in Oral and Maxillofacial Surgery, Sana'a University) — Sponsor-investigator
First posted
Nov 2, 2026
Start date
Jul 15, 2025
Primary completion
Mar 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Nov 2, 2026

Study contacts

Khadyjah A Alrassas, BDS
Contact
rassaskh23@gmail.com
+967 774 602 677

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion